Epivax Oncology Company
Epivax Oncology is a providence, RI and NY-based precision cancer immunotherapy company.
Founded Date:
2017-01-01
Last Funding Date:
2018-06-12
Industry:
Peptides and Proteins
Estimated Revenue:
$1M to $10M
Last Funding Type:
Venture - Series Unknown
Total Funding:
1524980
Headquarters:
Providence, Rhode Island, United States
Investors Number:
5
Employee Number:
1-10